US Bancorp
LMAT icon

US Bancorp’s LeMaitre Vascular LMAT Stock Holding History

US Bancorp’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.3K Sell
326
-607
-65% -$62.2K ﹤0.01% 3011
2026
Q1 		$102K Buy
933
+59
+7% +$5.62K ﹤0.01% 2379
2025
Q4 		$70.9K Sell
874
-78
-8% -$6.71K ﹤0.01% 2535
2025
Q3 		$83.3K Buy
952
+10
+1% +$893 ﹤0.01% 2425
2025
Q2 		$78.2K Sell
942
-448
-32% -$37.4K ﹤0.01% 2561
2025
Q1 		$117K Buy
1,390
+368
+36% +$34.2K ﹤0.01% 2321
2024
Q4 		$94.2K Sell
1,022
-76
-7% -$7.31K ﹤0.01% 2424
2024
Q3 		$102K Sell
1,098
-22
-2% -$1.91K ﹤0.01% 2387
2024
Q2 		$92.1K Sell
1,120
-13
-1% -$955 ﹤0.01% 2375
2024
Q1 		$75.2K Sell
1,133
-245
-18% -$15.1K ﹤0.01% 2494
2023
Q4 		$78.2K Sell
1,378
-68
-5% -$3.56K ﹤0.01% 2448
2023
Q3 		$78.8K Buy
1,446
+216
+18% +$12.8K ﹤0.01% 2240
2023
Q2 		$82.8K Sell
1,230
-2,378
-66% -$145K ﹤0.01% 2278
2023
Q1 		$186K Buy
3,608
+13
+0.4% +$631 ﹤0.01% 1889
2022
Q4 		$165K Sell
3,595
-2,725
-43% -$128K ﹤0.01% 1965
2022
Q3 		$321K Buy
6,320
+10
+0.2% +$500 ﹤0.01% 1599
2022
Q2 		$287K Buy
6,310
+155
+3% +$6.93K ﹤0.01% 1716
2022
Q1 		$285K Buy
6,155
+1
+0% +$45 ﹤0.01% 1797
2021
Q4 		$309K Sell
6,154
-429
-7% -$22.2K ﹤0.01% 1773
2021
Q3 		$349K Buy
6,583
+214
+3% +$12.1K ﹤0.01% 1696
2021
Q2 		$390K Sell
6,369
-618
-9% -$32.8K ﹤0.01% 1671
2021
Q1 		$341K Sell
6,987
-524
-7% -$24.6K ﹤0.01% 1692
2020
Q4 		$305K Buy
7,511
+480
+7% +$17.2K ﹤0.01% 1680
2020
Q3 		$229K Buy
7,031
+343
+5% +$10.3K ﹤0.01% 1707
2020
Q2 		$177K Sell
6,688
-1,029
-13% -$26.9K ﹤0.01% 1817
2020
Q1 		$192K Buy
7,717
+317
+4% +$9.79K ﹤0.01% 1684
2019
Q4 		$266K Buy
7,400
+50
+0.7% +$1.73K ﹤0.01% 1679
2019
Q3 		$251K Buy
7,350
+3,695
+101% +$118K ﹤0.01% 1695
2019
Q2 		$102K Sell
3,655
-70
-2% -$1.95K ﹤0.01% 2204
2019
Q1 		$115K Buy
3,725
+388
+12% +$10.4K ﹤0.01% 2121
2018
Q4 		$79K Sell
3,337
-1,154
-26% -$31.5K ﹤0.01% 2235
2018
Q3 		$174K Buy
4,491
+50
+1% +$1.8K ﹤0.01% 1939
2018
Q2 		$148K Buy
4,441
+115
+3% +$4.09K ﹤0.01% 2033
2018
Q1 		$157K Sell
4,326
-47
-1% -$1.63K ﹤0.01% 2016
2017
Q4 		$139K Buy
4,373
+1,069
+32% +$36.6K ﹤0.01% 2080
2017
Q3 		$123K Buy
3,304
+540
+20% +$18.4K ﹤0.01% 2121
2017
Q2 		$86K Buy
2,764
+1,209
+78% +$34.9K ﹤0.01% 2275
2017
Q1 		$38K Sell
1,555
-518
-25% -$12.2K ﹤0.01% 2631
2016
Q4 		$52K Buy
2,073
+1,668
+412% +$37K ﹤0.01% 2416
2016
Q3 		$8K Hold
405
– – ﹤0.01% 3052
2016
Q2 		$6K Hold
405
– – ﹤0.01% 3133
2016
Q1 		$6K Buy
+405
New +$5.81K ﹤0.01% 3129

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

US Bancorp's LMAT Position: Q2 2026 in Review

US Bancorp reduced its LeMaitre Vascular (LMAT) stake by 65% in Q2 2026, selling an estimated $62.2K and leaving 326 shares worth $31.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3011.

US Bancorp first reported a position in LMAT in Q1 2016 and has held it in 42 quarters since. The position peaked at $390K in Q2 2021. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • US Bancorp held 326 shares of LeMaitre Vascular worth $31.3K as of Q2 2026.
  • US Bancorp sold 607 LeMaitre Vascular shares in Q2 2026, an estimated $62.2K.
  • LeMaitre Vascular made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #3011 holding.
  • US Bancorp first reported a position in LeMaitre Vascular in Q1 2016 and has held it in 42 quarters since.
  • US Bancorp's LeMaitre Vascular position peaked at $390K in Q2 2021.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.